Hypertrophic cardiomyopathy

Jump to: navigation, search

For patient information click here

Hypertrophic cardiomyopathy
2369.jpg
Hypertrophic cardiomyopathy.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Genetics
Outflow Obstruction
Diastolic Dysfunction
Ischemia
Arrhythmogenesis
Anatomic Abnormalities
Histopathology
Gross Pathology

Causes

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Risk Factors For Sudden Death

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Diagnosis

Genetic Testing & Screening

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Cardiac Catheterization

Positron Emission Tomography

Electrophysiologic Testing

Stress Testing

Treatment

Medical Therapy

Treatment Strategy
Supportive Therapy
Pharmacotherapy
Guidelines

Invasive Therapy

Alcohol Septal Ablation
Septal Myectomy
Ventricular Pacing
Automatic Implantable Cardiac Defibrillator (AICD) Placement
Guidelines

Cardiac transplantation

Special Scenario

Asymptomatic Patients
Management During Childhood
Activities/Circumstances to Avoid
Management During Pregnancy

Hypertrophic cardiomyopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy

CDC on Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy in the news

Blogs on Hypertrophic cardiomyopathy</small>

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)

Overview

Classification

Pathophysiology

Genetics | Histopathologic Abnormalities | Anatomic Abnormalities | Outflow Obstruction | Ischemia | Arrhythmogenesis

Causes

Epidemiology and Demographcis

Screening

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Natural History, Prognosis and Sudden Cardiac Death Risk

Diagnosis

Genetic Testing & Screening | History and Symptoms | Physical examination | Electrocardiogram | Echocardiography | Cardiac MRI | Cardiac CT | Positron Emission Tomography

Treatment


Contraindicated medications

Idiopathic hypertrophic subaortic stenosis is considered an absolute contraindication to the use of the following medications:

Special Patient Populations

Asymptomatic Patients | Management During Childhood | Hypotension/Cardiovascular collapse | Pregnancy

2011 ACCF/AHA Guideline Recommendations

Diagnostic testing:

Electrocardiogram | Echocardiography | Stress Testing | Cardiac Magnetic Resonance | Cardiac CT | Positron Emission Tomography

Management:

| Invasive Therapies | Alcohol septal ablation | Septal Myectomy | Pacing | Selection of Patients for ICDs | Selection of ICD-Device type | Selection of Patients for Heart Transplantation

Related Chapters

Resources


Linked-in.jpg